Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ARVN vs ALEC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ALEC Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)
ALEC Overall Winner
6-Pillar Tally: ARVN 2 – 4 ALEC
Matrix Metrics: ARVN 3 – 7 ALEC
As of Nov 16, 2026, Alector, Inc. (ALEC) is the stronger overall head-to-head candidate over Arvinas, Inc (ARVN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). ARVN carries a Unified Composite Score of 52.9/100 (HOLD) at $6.74 (17.9x Forward P/E, -10.1% operating margin), whereas ALEC carries 37.0/100 (SELL) at $2.54 (8.5x Forward P/E, 21.8% operating margin).
- Composite vs. Pillar Nuance: While ARVN currently prints a higher short-term Unified Composite Score (52.9/100 HOLD vs. ALEC 37.0/100 SELL), ALEC captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (21.8% vs. -10.1% operating margin) and revenue trajectory (+4895.9% vs. -98.8% YoY).
- Technical & Structure Timing Caution: ARVN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 41.7); meanwhile ALEC trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 62.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About ARVN vs ALEC
ARVN
Arvinas, Inc
$6.74
-1.17% 1D
Market Cap
$449.9M
TTM Revenue
$275M
Forward P/E
17.9x
Beta / 30D Vol
1.40β · 66% Vol
Unified Composite Score
52.9
HOLD
Tech 54.0
Fund 59.0
Flow 71.0
Mom 54.0
Weinstein Technical Phase
Markdown · Sell / avoid
ALEC
Head-to-Head Winner
Alector, Inc. Common Stock
$2.54
+0.2% 1D
Market Cap
$364.7M
TTM Revenue
$173M
Forward P/E
8.5x
Beta / 30D Vol
1.58β · 95% Vol
Unified Composite Score
37.0
SELL
Tech 50.0
Fund 34.0
Flow 64.0
Mom 40.0
Weinstein Technical Phase
Neutral · Hold
6-Pillar Scorecard Institutional Category Breakdown (ARVN 2 – 4 ALEC)
1. Valuation Multiples
ALEC
Forward P/E
17.9x
8.5x
Trailing P/E
17.9x
6.6x
PEG Ratio
N/M
N/M
EV / Revenue
1.3x
1.8x
2. Growth & Scale
ARVN
Revenue Growth (YoY)
-98.8%
+4895.9%
Earnings Growth (YoY)
+0.0%
-86.3%
TTM Revenue (USD)
$275M
$173M
Market Cap
$449.9M
$364.7M
3. Profitability & Quality
ALEC
Gross Margin
96.7%
42.5%
Operating Margin
-10.1%
21.8%
Net Profit Margin
-3.5%
23.9%
Return on Equity (ROE)
-1.8%
47.5%
4. Balance Sheet & Cash Flow
ARVN
Cash Generation (TTM)
-$160M
-$150M
Cash Flow Margin
-58.0%
-86.5%
Net Cash / Leverage
$81M Net Cash
$54M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
ALEC
Options Structure Phase
BREAKDOWN
CONSOLIDATION
Current IV / %ile
108.7% (25th %ile)
77.3% (9th %ile)
Put/Call OI Skew
0.01x (Call-Skewed)
N/A
OBV Trend / Tech Phase
DISTRIBUTION · Markdown
ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat
ALEC
OpEx & R&D Intensity
N/A
20.7% of Rev ($36M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
High-Margin Pricing Power Moat
Supply-Chain Role
Biotechnology Operator
Biotechnology Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: ARVN (3) vs ALEC (7)| Institutional Metric | ARVN | ALEC | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $449.9M | $364.7M | ARVN | |
| Trailing P/E Ratio | 17.9x | 6.6x | ALEC | |
| Forward P/E Ratio | 17.9x | 8.5x | ALEC | |
| Revenue Growth (YoY) | -98.8% | +4895.9% | ALEC | |
| Operating Margin (TTM) | -10.1% | 21.8% | ALEC | |
| Net Profit Margin | -3.5% | 23.9% | ALEC | |
| Return on Equity (ROE) | -1.8% | 47.5% | ALEC | |
| 52-Week Range Position | 5% ($6–$15) | 83% ($1–$3) | ALEC | |
| Beta / 30D Volatility | 1.40β · 66% Vol | 1.58β · 95% Vol | ARVN | |
| Unified Institutional Score | 52.9 / 100 (HOLD) | 37.0 / 100 (SELL) | ARVN | |
| Trailing 12M Revenue (USD) | $275M | $173M | Scale | |
| Gross Profit Margin (TTM) | 96.7% | 42.5% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 1.3x EV/Rev | N/M PEG · 1.8x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$160M ($81M Net Cash) | -$150M ($54M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
ALEC +41.62 pp
3M Horizon
ALEC +42.37 pp
6M Horizon
ALEC +43.28 pp
1Y Horizon
ALEC +145.48 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ARVN Revenue | ALEC Revenue | ARVN Op. Margin | ALEC Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $10M | $30M | -306.3% | -208.3% | ALEC |
| FY2019 | $20M | $20M | -281.4% | -539.2% | ARVN |
| FY2020 | $20M | $20M | -554.1% | -925.1% | ARVN |
| FY2021 | $50M | $210M | -403.4% | -18.0% | ALEC |
| FY2022 | $130M | $130M | -200.3% | -103.2% | ALEC |
| FY2023 | $80M | $100M | -511.5% | -156.3% | ALEC |
| FY2024 | $260M | $100M | -95.0% | -144.2% | ARVN |
| FY2025 | $260M | $20M | -45.1% | -741.3% | ARVN |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
ARVN
BREAKDOWN
Current IV
108.7%
IV Percentile
25th %ile
Put/Call OI Skew
0.01x (Call-Skewed)
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact ARVN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
ALEC
CONSOLIDATION
Current IV
77.3%
IV Percentile
9th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact ALEC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
ARVN Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
ALEC Moat Profile
High-Margin Pricing Power Moat
Biotechnology Operator
OpEx & R&D Reinvestment
20.7% of Rev ($36M)
90D Engineering Disclosures
0 Published
Investor FAQ ARVN vs ALEC Key Questions & Quantitative Answers
As of Nov 16, 2026, Alector, Inc. (ALEC) is the stronger overall head-to-head candidate over Arvinas, Inc (ARVN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). ARVN carries a Unified Composite Score of 52.9/100 (HOLD) at $6.74 (17.9x Forward P/E, -10.1% operating margin), whereas ALEC carries 37.0/100 (SELL) at $2.54 (8.5x Forward P/E, 21.8% operating margin). Composite vs. Pillar Nuance: While ARVN currently prints a higher short-term Unified Composite Score (52.9/100 HOLD vs. ALEC 37.0/100 SELL), ALEC captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (21.8% vs. -10.1% operating margin) and revenue trajectory (+4895.9% vs. -98.8% YoY). Technical & Structure Timing Caution: ARVN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 41.7); meanwhile ALEC trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 62.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ARVN leads the Growth & Scale pillar: ARVN posts -98.8% YoY revenue growth and +0.0% YoY earnings growth on $275M TTM revenue (96.7% gross margin, -10.1% operating margin), compared with ALEC at +4895.9% YoY revenue growth and -86.3% YoY earnings growth on $173M TTM revenue (42.5% gross margin, 21.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ARVN cumulative revenue shifted +2500.0% while ALEC shifted -33.3%. In operating R&D and SG&A reinvestment, ARVN deploys N/A (0 90-day corporate R&D disclosures) versus 20.7% of Rev ($36M) (0 disclosures) for ALEC.
ALEC screens cheaper on headline valuation multiples. ARVN trades at 17.9x Forward P/E, 17.9x Trailing P/E, N/M PEG, and 1.3x EV/Revenue (-58.0% FCF margin), whereas ALEC trades at 8.5x Forward P/E, 6.6x Trailing P/E, N/M PEG, and 1.8x EV/Revenue (-86.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARVN (-1.8% ROE) versus ALEC (47.5% ROE) capital efficiency.
In options market volatility and institutional positioning, ARVN carries 108.7% implied volatility (25th %ile, Balanced (25th–60th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.40β · 66% Vol realized risk). By comparison, ALEC carries 77.3% implied volatility (9th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.58β · 95% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
ALEC vs ARVN · Reverse Pair
ARVN vs KYMR
· Sector Peer
ARVN vs DNLI
· Sector Peer
ARVN vs RCUS
· Sector Peer
ALEC vs GOSS
· Sector Peer
ALEC vs STOK
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem